Elon Musk's Neuralink has popularized brain-computer interfaces (BCI) through invasive implants aimed at addressing disabilities. However, companies like China's BrainCo are betting on non-invasive methods that do not require surgery, potentially appealing to a broader market.
BrainCo, founded in 2015, has developed FDA-approved bionic hands that translate neural signals into movement and other wearables aimed at improving quality of life. The company has raised approximately $280 million in funding and plans to expand its technology from medical applications to consumer electronics.
The non-invasive BCI sector is gaining traction, with advancements in ultrasound-based techniques and AI-driven signal processing. As the U.S. and China compete in this emerging field, China's government support for BCI technology could accelerate its development and commercialization.
Industry experts note that while invasive implants may offer certain advantages, non-invasive methods could provide safer and more accessible solutions. The future of BCI technology remains uncertain, with significant ethical considerations and market potential yet to be fully realized